MorphoSys AG
ISIN: DE0006632003 | Ticker: MOR | LEI: 529900493806K77LRE72
Country: Germany
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines.
Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer.
1992
Served areaWorldwide
Headcount732
HeadquartersSemmelweisstr. 7, 82152 Planegg – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 20.09.23 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 775.25 |
| 07.06.23 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 52,800.00 |
| 06.06.23 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 24,280.00 |
| 30.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 13,800.00 |
| 30.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 7,479.00 |
| 30.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 4,186.00 |
| 30.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 2,698.00 |
| 29.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 8,100.00 |
| 29.11.22 | Reissner, Thomas | Supervisory board | Buy | EUR 5,000.00 |
| 28.11.22 | Vermeylen, Krisja | Supervisory board | Buy | EUR 14,860.00 |
DE0006632003
LEI529900493806K77LRE72
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustrySDAX
TecDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.